# Study of Fecal Microbiota Transplantation (FMT) in Severe IBS Patients

> **NCT06433180** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 150 (estimated)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DRUG:** Administration of fecal microbiota transplantation ( FMT capsules)
- **DRUG:** Administration of the sham (PLACEBO)

## Key facts

- **NCT ID:** NCT06433180
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2028-07-15
- **Final completion:** 2029-07-15
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06433180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06433180, "Study of Fecal Microbiota Transplantation (FMT) in Severe IBS Patients". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT06433180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*